Pernod Ricard betting on growth from green agenda
April 3, 2019Ghosn tweets about telling the truth as report says prosecutors readying new case
April 3, 2019Roche extends Spark offer after getting only 29 percent
at
Roche Holding has extended until May 2 its $4.3 billion offer for U.S. gene therapy specialist Spark Therapeutics, the Swiss drugmaker said after getting only 29.4 percent of Spark’s shares in a tender originally due to end on Wednesday.
Powered by WPeMatico
